For reference only. Please follow the manual included in your kit for instructions.
Catalog Number
RD82212A
Western blot analysis of extracts of various cell lines using Factor IX / F9 Polyclonal Antibody at dilution of 1:1000.
Immunofluorescence analysis of Rat liver using Factor IX / F9 Polyclonal Antibody at dilution of 1:100 (40x lens). Blue: DAPI for nuclear staining.
Immunofluorescence analysis of Human placenta using Factor IX / F9 Polyclonal Antibody at dilution of 1:100 (40x lens). Blue: DAPI for nuclear staining.
This gene encodes vitamin K-dependent coagulation factor IX that circulates in the blood as an inactive zymogen. This factor is converted to an active form by factor XIa, which excises the activation peptide and thus generates a heavy chain and a light chain held together by one or more disulfide bonds. The role of this activated factor IX in the blood coagulation cascade is to activate factor X to its active form through interactions with Ca+2 ions, membrane phospholipids, and factor VIII. Alterations of this gene, including point mutations, insertions and deletions, cause factor IX deficiency, which is a recessive X-linked disorder, also called hemophilia B or Christmas disease. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing.
Immunogen Information
Immunogen
Recombinant fusion protein of human Factor IX / F9 (NP_000124.1).